Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.

Research paper from Europe PMC. Evidence status: source reported.

Published

2026-10-01

Source reference

MED:42246978

DOI

10.1093/eurheartj/ehag400

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Holtrop J, Gynnild MN, Deo SV, Lim CE, Logothetis SB, Läll K, Oksanen M, Dalen H, Munkhaugen J, Ueda P, Jernberg T, Tuñón J, Mahíllo Fernández I, Saltvedt I, Ellekjær H, Teraa M, van der Meer MG, Ruigrok YM, Võsa U, Chlabicz M, Kaminski K, Steg PG, Burazor I, Mägi R, Tillmann T, Wood DA, Ray KK, de Bacquer D, Martikainen J, McEvoy JW, Kaptoge S, Visseren FLJ, Di Angelantonio E, Bhatt DL, Wood A, Hageman SHJ, Dorresteijn JAN, UCC-SMART study group & the ESC Cardiovascular Risk Collaboration. · Eur Heart J · research-article; multicenter study; journal article · Found via: CPRD, NHS England agreement reference

Source: https://europepmc.org/article/MED/42246978. Captured 2026-10-25.

Limitations: Discovered through a Europe PMC keyword search for CPRD, NHS England agreement reference. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.